Salugan, Nina H.

HRN: 26-48-68  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/19/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/19/2026
06/25/2026
IV
1.5g
Q6h
Bed Sore
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: